Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Dermatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Paroxetine Targets Neurovascular-Immune Pathways in Rosacea
June 2026
A proteomic study reveals how paroxetine may improve refractory rosacea by influencing neurovascular-immune pathways and identifying potential treatment biomarkers.
Read more
19 Dec 2025
Addictive Behaviours Common Among Patients with Chronic Skin Diseases Across Europe
A Pan-European study reports high rates of addictive behaviours among patients with chronic skin diseases, linked to poorer quality of life and key demographic factors.
17 Dec 2025
Systemic Therapy Preferences in Treatment-Naïve Atopic Dermatitis and Psoriasis
Most systemic therapy-naïve patients with moderate-to-severe atopic dermatitis or psoriasis in Germany wish to escalate treatment, with clear preferences for administration route.
15 Dec 2025
Distinct Microbial Signatures Linked to Acne in Diverse Adolescent Population
A large, multiethnic study reveals distinct facial microbiota patterns in adolescents with acne, identifying key bacterial species linked to acne pathology.
13 Dec 2025
Study Finds No Clear Increase in Birth-Defect Risk from Topical Retinoids
A new Nordic study reports no clear increase in major congenital malformations among infants exposed to topical retinoids in early pregnancy.
11 Dec 2025
Metabolic Liver Disease Tied to Higher Risk of Androgenetic Alopecia
New research shows metabolic liver disease is linked to increased androgenetic alopecia risk, with stronger effects in women and those with unhealthy lifestyle patterns.
9 Dec 2025
Glycolytic Pathways Drive Systemic Inflammation in Dermatomyositis
Fibroblasts fuel skin and systemic inflammation via a CXCL10–glycolysis axis in dermatomyositis, offering new metabolic treatment opportunities.
7 Dec 2025
Dupilumab Improves Quality of Life in Chronic Urticaria
A phase 3 trial shows dupilumab significantly improves quality of life in omalizumab-naïve patients with chronic spontaneous urticaria.
5 Dec 2025
IMCAS World Congress 2026: Shaping the Future of Dermatologic Science and Patient Safety
IMCAS World Congress 2026 unites global dermatology experts to explore advances in science, aesthetics, and complication management across lasers, dermatology, and injectables.
Loading posts...
« Previous
1
…
8
9
10
11
12
…
51
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View